Cargando…

Generation and utilization of polyfunctional anti-tumor CD4+ T cells

Detalles Bibliográficos
Autores principales:	Zhou, Gang, Ding, Zhi-Chun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645179/ http://dx.doi.org/10.1186/2051-1426-3-S2-P63

Ejemplares similares

IL7 signaling confers polyfunctionality to antitumor CD4+ T cells
por: Zhou, Gang, et al.
Publicado: (2014)

Increased differentiation associates with decreased polyfunctionality for HIV but not CMV-specific CD8+ T cell responses
por: Riou, C, et al.
Publicado: (2012)

P18-02. Peptide pulsed dendritic cells allows for induction of polyfunctional CD4+ T cell responses and help CD8+ T cell targeting subdominant CTL epitopes
por: Fomsgaard, A, et al.
Publicado: (2009)

P17-04. Targeting HIV peptides to human dendritic cells via CD40 elicits expansion of multi-epitope polyfunctional CD4+ and CD8+ T cells in HIV patients
por: Flamar, A, et al.
Publicado: (2009)

Polyfunctional incompletely differentiated CD8+ T cells accumulates after adoptive transfer of tumor-infiltrating lymphocytes and establish immunological memory in patients with metastatic melanoma
por: Donia, Marco, et al.
Publicado: (2015)

P16-17. Antigen sensitivity is a major determinant of CD8+ T-cell polyfunctionality and HIV suppressive activity
por: Almeida, J, et al.
Publicado: (2009)

Unleashing the power of anti-tumor CD4+ T cells: novel insights into the curative mechanisms of chemoimmunotherapy for cancer
por: Habtetsion, Tsadik G, et al.
Publicado: (2015)

Upregulation of neuroreceptors on CD4+ and CD8+ T cells promotes their anti-tumor function
por: de Aquino, Maria Teresa, et al.
Publicado: (2015)

P16-15. Epitope mapping of HIV-specific CD8+ T-cells responses by polyfunctional and proliferation responses reveal distinct specificity defined by function
por: Richmond, ME, et al.
Publicado: (2009)

Adjuvant IL-7 potentiates adoptive T cell therapy by amplifying and sustaining polyfunctional antitumor CD4+ T cells
por: Ding, Zhi-Chun, et al.
Publicado: (2017)

Immunological and polyfunctional T cell profiling following therapy with DPX-Survivac as a predictive tool of vaccine efficacy
por: Karkada, Mohan, et al.
Publicado: (2013)

Human herpesvirus 8 replicates in primary B lymphocytes and induces polyfunctional cytokine and chemokine responses
por: Knowlton, Emilee, et al.
Publicado: (2012)

Polyfunctional CD4(+) T Cells As Targets for Tuberculosis Vaccination
por: Lewinsohn, Deborah A., et al.
Publicado: (2017)

Generation of tumor antigen-specific CD4+ and CD8+ T cells by simultaneous MHC-I and -II epitope presentation in vitro and in vivo
por: Wehner, Carina, et al.
Publicado: (2014)

Talilmogene Iaherparepvec generates systemic T-cell-mediated anti-tumor immunity
por: Piasecki, Julia, et al.
Publicado: (2013)

Combination immunotherapy with anti-CTLA-4 and interleukin-2 redirects regulatory T cells into tumor-draining lymph nodes and expands anti-tumor CD8+ T cells in the tumor microenvironment
por: Broucek, Joseph, et al.
Publicado: (2014)

The human CD40 agonistic antibody ADC-1013 generates immune mediated anti-tumor effects in syngeneic tumor models in hCD40 transgenic mice
por: Mangsbo, Sara M, et al.
Publicado: (2014)

CD4(+) T cells support polyfunctionality of cytotoxic CD8(+) T cells with memory potential in immunological control of tumor
por: Imai, Naoko, et al.
Publicado: (2020)

Optimization of ex vivo expansion of HER2 specific polyfunctional Th1/Th17 cells from HER2 vaccine primed PBMC
por: Dang, Yushe, et al.
Publicado: (2013)

Bystander memory CD8 T cell proliferation after anti-CD40/IL-2 treatment is independent of CD4 T cells
por: Grossenbacher, Steven K, et al.
Publicado: (2013)

Novel strategy to identify MHC class II-promiscuous CD4+ peptides from tumor antigens for utilization in vaccination
por: Datta, Jashodeep, et al.
Publicado: (2014)

Combination of EP4 antagonist and checkpoint inhibitors promotes anti-tumor effector T cells in preclinical tumor models
por: Bao, Xingfeng, et al.
Publicado: (2015)

Effect of HIV on production of anti-viral factors by HIV-specific CD4+ T cells
por: Hioe, Catarina, et al.
Publicado: (2006)

Mcl-1 expression influcences CD8+ anti-tumor immunity.
por: Pfannenstiel, Lukas W, et al.
Publicado: (2015)

Tumor associated MUC1 carried by microvesicles is cross-processed by dendritic cells generating CD8+ T cell response
por: Zizzari, Ilaria G, et al.
Publicado: (2013)

Polyfunctional response by ImmTAC (IMCgp100) redirected CD8(+) and CD4(+) T cells
por: Boudousquie, Caroline, et al.
Publicado: (2017)

Enhanced tumor immunotherapy by polyfunctional CD19-CAR T cells engineered to secrete anti-CD47 single-chain variable fragment
por: Qiu, Yingqi, et al.
Publicado: (2023)

Detection of antibody therapy-induced anti-tumor immune responses using anti-CD8 immuno-pet
por: Tavare, Richard, et al.
Publicado: (2015)

Diagnosis of infection utilizing accellix CD64
por: Sprung, CL, et al.
Publicado: (2015)

PD-1 blockade reverses viral infection-induced loss of anti-tumor CD8+ T cell responses
por: Huelsmann, Erica, et al.
Publicado: (2013)

CXCR5+CD8+ T cells are localized in B cell follicles and germinal centers and exhibit regulatory and anti-tumor function
por: Chu, Fuliang, et al.
Publicado: (2015)

Acute viral infection results in a PD-1-dependent loss of anti-tumor CD8+ T cell responses: implications for tumor immunotherapy
por: Kohlhapp, Frederick, et al.
Publicado: (2015)

Antigen presentation by tumor infiltrating B cells influences CD4 T cell phenotype and function in primary lung cancer patient tumors
por: Bruno, Tullia, et al.
Publicado: (2015)

Treatment of B cells malignancies with anti-CD19 CAR+, TCR-, CD52- allogeneic T cells
por: Mannioui, Cécile Schiffer, et al.
Publicado: (2013)

Single-cell polyfunctional proteomics of CD4 cells from patients with AML predicts responses to anti–PD-1–based therapy
por: Abbas, Hussein A., et al.
Publicado: (2021)

Evaluating Cellular Polyfunctionality with a Novel Polyfunctionality Index
por: Larsen, Martin, et al.
Publicado: (2012)

Delta inulin-based adjuvants promote the generation of polyfunctional CD4(+) T cell responses and protection against Mycobacterium tuberculosis infection
por: Counoupas, Claudio, et al.
Publicado: (2017)

Combination therapies augment the anti-tumor activity of agonist CD27 mAb in human CD27 transgenic mouse models
por: He, Li-Zhen, et al.
Publicado: (2013)

The signalling signature downstream of the notch receptor in CD4(+)CD25(high )regulatory T cells in RA defines anergic cells: insight into resistance to anti-tumour necrosis factor therapies
por: Buch, MH, et al.
Publicado: (2005)

First generation anti-CD19 chimeric antigen receptor-modified T cells for management of B cell malignances: initial analysis of an ongoing Phase I clinical trial
por: Evans, Manon, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_7rktqbgsmdjcsfkcguvcpooa3v